YTHDF3-mediated FLCN/cPLA2 axis improves cardiac fibrosis via suppressing lysosomal function.
Zhang Y, Diao HT, Leng MY, Wu YZ, Huang BY, Li X, Tang WY, Wu KL, Tan HL, Wang L, Lu W, Xiong A, Shao XQ, Liang HH, Guo J.
Zhang Y, et al. Among authors: guo j.
Acta Pharmacol Sin. 2025 Jan 13. doi: 10.1038/s41401-024-01425-2. Online ahead of print.
Acta Pharmacol Sin. 2025.
PMID: 39806064